Goff Brian Insider Trades

Insider Trading History

Track insider trading activity for Goff Brian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $497k 32,609 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$15.25
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $1.44M 40,500 shares
Last Trade
Apr 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 39,028 shares
$35.20
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $6.57M 184,508 shares
Last Trade
Apr 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$662k 19,068 shares
$34.71
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $6.8M 191,104 shares
Last Trade
Apr 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 39,028 shares
$35.20
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $5.86M 164,548 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$523k 18,055 shares
$28.96
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $925k 26,000 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.15M 39,500 shares
$29.20
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $6.07M 170,466 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.15M 39,500 shares
$29.20
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $6.19M 174,000 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.71M 222,000 shares
$30.23
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $909k 25,528 shares
Last Trade
Dec 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 38,278 shares
$27.33
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $5.09M 143,103 shares
Last Trade
Dec 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$507k 18,703 shares
$27.09
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $5.31M 149,333 shares
Last Trade
Dec 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 38,278 shares
$27.33
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $4.79M 134,613 shares
Last Trade
Aug 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$811k 22,691 shares
$35.76
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $4.4M 123,528 shares
Last Trade
Aug 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$406k 11,085 shares
$36.67
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Aug 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$811k 22,691 shares
$35.76
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $3.98M 111,922 shares
Last Trade
Jun 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$627k 18,700 shares
$33.54
$35.59
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $357k 23,409 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95.8k 11,450 shares
$8.37
$15.25
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $3.29M 92,345 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$460k 12,947 shares
$35.54
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $5.07M 142,500 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.06M 142,500 shares
$35.54
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $2.8M 78,792 shares
Last Trade
Aug 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$474k 11,091 shares
$42.75
$35.59
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Chief Executive Officer
Holding Value $3.2M 89,883 shares
Last Trade
Aug 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$994k 22,691 shares
$43.79
$35.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up